Personalized methods to assess autism risk in children
Individualized approaches to determining likelihood of ASD caseness
This study is working on creating better ways to diagnose autism in children by personalizing the screening tools to fit each child's unique traits, so that we can more accurately identify those who might be at risk for autism.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10831052 on NIH RePORTER |
What this research studies
This research focuses on improving the accuracy of autism spectrum disorder (ASD) diagnoses by developing individualized screening and diagnostic tools. It aims to address the variability in how different children present symptoms of ASD based on their unique demographic, developmental, and behavioral characteristics. By tailoring assessment methods to each child's profile, the research seeks to enhance the effectiveness of identifying those at risk for ASD. The approach involves analyzing data from diverse populations to refine diagnostic criteria and improve decision-making in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who are being evaluated for autism spectrum disorder.
Not a fit: Patients who are older than 11 years or do not exhibit symptoms related to autism spectrum disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and personalized diagnoses of autism, allowing for earlier and more effective interventions.
How similar studies have performed: Previous research has shown that individualized approaches to diagnosis can improve outcomes in similar populations, indicating a promising direction for this study.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Bishop, Somer L. — University of California, San Francisco
- Study coordinator: Bishop, Somer L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.